131 related articles for article (PubMed ID: 1827414)
1. A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors.
Schmidt A; Audigier S; Barberis C; Jard S; Manning M; Kolodziejczyk AS; Sawyer WH
FEBS Lett; 1991 Apr; 282(1):77-81. PubMed ID: 1827414
[TBL] [Abstract][Full Text] [Related]
2. A new series of photoactivatable and iodinatable linear vasopressin antagonists.
Carnazzi E; Aumelas A; Barberis C; Guillon G; Seyer R
J Med Chem; 1994 Jun; 37(12):1841-9. PubMed ID: 8021923
[TBL] [Abstract][Full Text] [Related]
3. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptors.
Barbeis C; Balestre MN; Jard S; Tribollet E; Arsenijevic Y; Dreifuss JJ; Bankowski K; Manning M; Chan WY; Schlosser SS
Neuroendocrinology; 1995 Aug; 62(2):135-46. PubMed ID: 8584113
[TBL] [Abstract][Full Text] [Related]
5. 125I-d(CH2)5[Tyr(Me)2, Tyr(NH2)9]AVP: iodination and binding characteristics of a vasopressin receptor ligand.
Elands J; Barberis C; Jard S; Lammek B; Manning M; Sawyer WH; de Kloet ER
FEBS Lett; 1988 Mar; 229(2):251-5. PubMed ID: 2964381
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.
Ammar A; Roseau S; Butlen D
Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099
[TBL] [Abstract][Full Text] [Related]
7. Novel approach to the design of synthetic radioiodinated linear V1A receptor antagonists of vasopressin.
Manning M; Bankowski K; Barberis C; Jard S; Elands J; Chan WY
Int J Pept Protein Res; 1992; 40(3-4):261-7. PubMed ID: 1478783
[TBL] [Abstract][Full Text] [Related]
8. Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors.
Ala Y; Morin D; Mahé E; Cotte N; Mouillac B; Jard S; Barberis C; Tribollet E; Dreifuss JJ; Sawyer WH; Wo NC; Chan WY; Kolodziejczyk AS; Cheng LL; Manning M
Eur J Pharmacol; 1997 Jul; 331(2-3):285-93. PubMed ID: 9274991
[TBL] [Abstract][Full Text] [Related]
9. 125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand.
Elands J; Barberis C; Jard S; Tribollet E; Dreifuss JJ; Bankowski K; Manning M; Sawyer WH
Eur J Pharmacol; 1988 Mar; 147(2):197-207. PubMed ID: 2835249
[TBL] [Abstract][Full Text] [Related]
10. Iodination of vasopressin analogues with agonistic and antagonistic properties: effects on biological properties and affinity for vascular and renal vasopressin receptors.
Jard S; Lombard C; Seyer R; Aumelas A; Manning M; Sawyer WH
Mol Pharmacol; 1987 Sep; 32(3):369-75. PubMed ID: 2959851
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications.
Durroux T; Peter M; Turcatti G; Chollet A; Balestre MN; Barberis C; Seyer R
J Med Chem; 1999 Apr; 42(7):1312-9. PubMed ID: 10197974
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin-binding sites in the pig pituitary gland: competition by novel vasopressin antagonists suggests the existence of an unusual receptor subtype in the anterior lobe.
Arsenijevic Y; Dubois-Dauphin M; Tribollet E; Manning M; Sawyer WH; Dreifuss JJ
J Endocrinol; 1994 Jun; 141(3):383-91. PubMed ID: 8071638
[TBL] [Abstract][Full Text] [Related]
13. Characterization and localization of oxytocin receptors in the rat testis.
Bathgate RA; Sernia C
J Endocrinol; 1994 May; 141(2):343-52. PubMed ID: 8046305
[TBL] [Abstract][Full Text] [Related]
14. Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells.
Serradeil-Le Gal C; Herbert JM; Delisee C; Schaeffer P; Raufaste D; Garcia C; Dol F; Marty E; Maffrand JP; Le Fur G
Am J Physiol; 1995 Jan; 268(1 Pt 2):H404-10. PubMed ID: 7840290
[TBL] [Abstract][Full Text] [Related]
15. Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin.
Manning M; Stoev S; Kolodziejczyk A; Klis WA; Kruszynski M; Misicka A; Olma A; Wo NC; Sawyer WH
J Med Chem; 1990 Nov; 33(11):3079-86. PubMed ID: 2231609
[TBL] [Abstract][Full Text] [Related]
16. Probing the V1a vasopressin receptor binding site with pyroglutamate-substituted linear antagonists.
Howl J; Yarwood NJ; Stock D; Wheatley M
Neuropeptides; 1996 Feb; 30(1):73-9. PubMed ID: 8868303
[TBL] [Abstract][Full Text] [Related]
17. Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain.
Dorsa DM; Brot MD; Shewey LM; Meyers KM; Szot P; Miller MA
Synapse; 1988; 2(3):205-11. PubMed ID: 2975069
[TBL] [Abstract][Full Text] [Related]
18. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
Reymond-Marron I; Tribollet E; Raggenbass M
Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
[TBL] [Abstract][Full Text] [Related]
19. Linear V1-vascular vasopressin antagonists suitable for radioiodination, biotinylation, and fluorescent labeling.
Thibonnier M; Bayer AL; Madhun Z
Am J Physiol; 1993 Dec; 265(6 Pt 1):E906-13. PubMed ID: 8279546
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.
Jard S; Gaillard RC; Guillon G; Marie J; Schoenenberg P; Muller AF; Manning M; Sawyer WH
Mol Pharmacol; 1986 Aug; 30(2):171-7. PubMed ID: 3016500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
